Advanced search
Publication Cover
Ultrastructural Pathology Volume 44, 2020 - Issue 4-6
Submit an article Journal homepage
165
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis in a young female: a case study

Prit Pal Singha Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, IndiaCorrespondence[email protected]
,
Amresh Krishnaa Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
,
Alok Sharmab Department of Renal Pathology & Electron Microscopy, National Reference Lab, Dr Lal Pathlab, New Delhi, India
&
Om Kumara Department of Nephrology, Indira Gandhi Institute of Medical Sciences, Sheikhpura, Patna, India
Pages 501-504 | Received 26 May 2020, Accepted 02 Jul 2020, Published online: 13 Jul 2020

References

  • Iskandar SS, Falk RJ, Jennette JC. Clinical and pathologic features of fibrillary glomerulonephritis. Kidney Int. 1992;42:1401–1407. doi:10.1038/ki.1992.433.
  • Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D’agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003;63:1450–1461. doi:10.1046/j.1523-1755.2003.00853.x.
  • Nasr SH, Valeri AM, Cornell LD, et al. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011;6:775–784. doi:10.2215/CJN.08300910.
  • Rosenstock JL, Markowitz GS. Fibrillary glomerulonephritis: an update. Kidney Int Rep. 2019;4:917–922. doi:10.1016/j.ekir.2019.04.013.
  • Schober FP, Jobson MA, Poulton CJ, et al. Clinical features and outcomes of a racially diverse population with fibrillary glomerulonephritis. Am J Nephrol. 2017;45(3):248–256. doi:10.1159/000455390.
  • Blume C, Ivens K, May P, et al. Fibrillary glomerulonephritis associated with crescents as a therapeutic challenge. Am J Kidney Dis. 2002;40:420‐5. doi:10.1053/ajkd.2002.34548.
  • Nilajgi S, Killen JP, Baer R, Renaut P, Mantha M. Fibrillary glomerulonephritis: presenting as crescentic glomerulonephritis causing rapidly progressive renal failure. NDT Plus. 2011;4:413‐5.
  • Sharma P, Kuperman M, Racusen L, Geetha D. Fibrillary glomerulonephritis presenting as rapidly progressive glomerulonephritis. Am J Kidney Dis. 2012;60:157‐9. doi:10.1053/j.ajkd.2011.12.024.
  • Shah HH, Thakkar J, Pullman JM, Mathew AT. Fibrillary glomerulonephritis presenting as crescentic glomerulonephritis. Indian J Nephrol. 2017;27:157–160. doi:10.4103/0971-4065.200521.
  • Javaugue V, Karras A, Glowacki F, et al. Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients. Am J Kidney Dis. 2013;62:679–690. doi:10.1053/j.ajkd.2013.03.031.
  • Andeen NK, Troxell ML, Riazy M, et al. Fibrillary Glomerulonephritis: clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort. CJASN. 2019;14:1741–1750. doi:10.2215/CJN.03870319.
  • Nasr SH, Vrana JA, Dasari S, et al. DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis. Kidney Int Rep. 2018;3:56–64. doi:10.1016/j.ekir.2017.07.017.
  • Alexander MP, Dasari S, Vrana JA, et al. Congophilic fibrillary glomerulonephritis: a case series. Am J Kidney Dis. 2018;72:325–336. doi:10.1053/j.ajkd.2018.03.017.
  • Hogan J, Restivo M, Canetta PA, et al. Rituximab treatment for fibrillary glomerulonephritis. Nephrol Dial Transplant. 2014;29:1925–1931. doi:10.1093/ndt/gfu189.
  • Mallett A, Tang W, Hart G, et al. End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy – outcomes in 66 consecutive ANZDATA registry cases. Am J Nephrol. 2015;42:177–184. doi:10.1159/000440815.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.